NCT00799266View on ClinicalTrials.gov

An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids

PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 4, 2008

Primary Completion Date

March 5, 2018

Study Completion Date

March 5, 2018

Conditions
Osteoporosis
Interventions
DRUG

Zoledronic acid

intravenous infusion

DRUG

Placebo

intravenous infusion

Trial Locations (12)

1085

Novartis Investigative Site, Budapest

2013

Novartis Investigative Site, Soweto

2145

Novartis Investigative Site, Westmead

119991

Novartis Investigative Site, Moscow

195067

Novartis Investigative Site, Saint Petersburg

V6H 3V4

Novartis Investigative Site, Vancouver

R3E 0Z2

Novartis Investigative Site, Winnipeg

K1H 8L1

Novartis Investigative Site, Ottawa

H3H 1P3

Novartis Investigative Site, Montreal

H3T 1C5

Novartis Investigative Site, Montreal

B4 6NH

Novartis Investigative Site, West Midlands

M14 0JH

Novartis Investigative Site, Manchester

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY